SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Lasertec Corporation (LSRCY) trades at a trailing P/E of 0.3. Trailing earnings yield is 344.83%. PEG 0.01 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.3); PEG ≤ 1.0 — Peter Lynch undervalued (0.01); earnings yield beats bond yields (344.83%).
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 344.83% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 87/100 with 6/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LSRCY
Valuation Multiples
P/E (TTM)0.3
Forward P/EN/A
PEG Ratio0.01
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.10
EV/EBITDA0.0
Per Share Data
EPS (TTM)$187.56
Book Value / Share$0.00
Revenue / Share$557.20
FCF / Share$0.00
Yields & Fair Value
Earnings Yield344.83%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$7.15 |
$15.29B |
$3.23B |
21.1% |
| 2017 |
$7.83 |
$17.28B |
$3.53B |
20.5% |
| 2018 |
$9.68 |
$21.25B |
$4.37B |
20.5% |
| 2019 |
$13.15 |
$28.77B |
$5.93B |
20.6% |
| 2020 |
$23.98 |
$42.57B |
$10.82B |
25.4% |
| 2021 |
$42.66 |
$70.25B |
$19.25B |
27.4% |
| 2022 |
$55.07 |
$90.38B |
$24.85B |
27.5% |
| 2023 |
$102.29 |
$152.83B |
$46.16B |
30.2% |
| 2024 |
$130.90 |
$213.51B |
$59.08B |
27.7% |
| 2025 |
$187.56 |
$251.48B |
$84.65B |
33.7% |
